Long-Term, Open Label Atomoxetine Study

Clinical trial NCT00190684 · COMPLETED

Trial details

NCT number: NCT00190684
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2000-08-01
Primary completion: 2009-10-01
Enrollment: 1553

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.